TY - JOUR
T1 - Functional methionine synthase deficiency due to cblG disorder
T2 - A report of two patients and a review
AU - Harding, Cary O.
AU - Arnold, Georgianne
AU - Barness, Lewis A.
AU - Wolff, Jon A.
AU - Rosenblatt, David S.
PY - 1997/9/5
Y1 - 1997/9/5
N2 - Functional methionine synthase deficiency due to abnormal methylcobalamin metabolism causes megaloblastic anemia, moderate to severe developmental delay, lethargy, and anorexia in association with homocystinuria. Patients with this disorder of cobalamin metabolism can be classified into two separate groups, cblE or cblG, primarily on the basis of complementation analysis with cultured skin fibroblasts. We describe two unrelated boys, ages 3 and 5 years, with the cblG defect in methylcobalamin synthesis. Both children presented with severe developmental delay, lethargy, anorexia, and megaloblastic anemia. The diagnosis of homocystinuria was delayed in each case due to difficulties with detection of small amounts of homocystine in physiologic samples. The clinical course of cblG disease is favorably altered by treatment with intra-muscular hydroxycobalamin. Megaloblastosis in the presence of adequate supplies of cobalamin and folate in the blood must alert the clinician to the possibility of functional methionine synthase deficiency and should prompt a careful search for associated biochemical hallmarks, including homocystinuria/emia.
AB - Functional methionine synthase deficiency due to abnormal methylcobalamin metabolism causes megaloblastic anemia, moderate to severe developmental delay, lethargy, and anorexia in association with homocystinuria. Patients with this disorder of cobalamin metabolism can be classified into two separate groups, cblE or cblG, primarily on the basis of complementation analysis with cultured skin fibroblasts. We describe two unrelated boys, ages 3 and 5 years, with the cblG defect in methylcobalamin synthesis. Both children presented with severe developmental delay, lethargy, anorexia, and megaloblastic anemia. The diagnosis of homocystinuria was delayed in each case due to difficulties with detection of small amounts of homocystine in physiologic samples. The clinical course of cblG disease is favorably altered by treatment with intra-muscular hydroxycobalamin. Megaloblastosis in the presence of adequate supplies of cobalamin and folate in the blood must alert the clinician to the possibility of functional methionine synthase deficiency and should prompt a careful search for associated biochemical hallmarks, including homocystinuria/emia.
KW - Homocystinuria
KW - Megaloblastic anemia
KW - Vitamin B
UR - http://www.scopus.com/inward/record.url?scp=0030769174&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030769174&partnerID=8YFLogxK
U2 - 10.1002/(SICI)1096-8628(19970905)71:4<384::AID-AJMG3>3.0.CO;2-U
DO - 10.1002/(SICI)1096-8628(19970905)71:4<384::AID-AJMG3>3.0.CO;2-U
M3 - Article
C2 - 9286442
AN - SCOPUS:0030769174
SN - 1552-4825
VL - 71
SP - 384
EP - 390
JO - American Journal of Medical Genetics, Part A
JF - American Journal of Medical Genetics, Part A
IS - 4
ER -